354 related articles for article (PubMed ID: 34573278)
21. [B cell abnormalities and therapeutic strategies in systemic sclerosis].
Yoshizaki A
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):197-206. PubMed ID: 27320935
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic profiles for precision medicine in systemic sclerosis; stepping forward from single biomarkers towards pathophysiological panels.
Smeets RL; Kersten BE; Joosten I; Kaffa C; Alkema W; Koenen HJPM; Vonk MC
Autoimmun Rev; 2020 May; 19(5):102515. PubMed ID: 32173517
[TBL] [Abstract][Full Text] [Related]
23. Current Concepts on the Pathogenesis of Systemic Sclerosis.
Truchetet ME; Brembilla NC; Chizzolini C
Clin Rev Allergy Immunol; 2023 Jun; 64(3):262-283. PubMed ID: 34487318
[TBL] [Abstract][Full Text] [Related]
24. Genetic and epigenetic abnormalities in systemic sclerosis.
Makino T; Jinnin M
J Dermatol; 2016 Jan; 43(1):10-8. PubMed ID: 26782002
[TBL] [Abstract][Full Text] [Related]
25. Altered B lymphocyte function induces systemic autoimmunity in systemic sclerosis.
Sato S; Fujimoto M; Hasegawa M; Takehara K; Tedder TF
Mol Immunol; 2004 Nov; 41(12):1123-33. PubMed ID: 15482848
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic modulation as a therapy in systemic sclerosis.
O'Reilly S
Rheumatology (Oxford); 2019 Feb; 58(2):191-196. PubMed ID: 29579252
[TBL] [Abstract][Full Text] [Related]
27. An update on biomarker discovery and use in systemic sclerosis.
Matsushita T; Takehara K
Expert Rev Mol Diagn; 2017 Sep; 17(9):823-833. PubMed ID: 28730919
[TBL] [Abstract][Full Text] [Related]
28. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA TSIX is upregulated in scleroderma dermal fibroblasts and controls collagen mRNA stabilization.
Wang Z; Jinnin M; Nakamura K; Harada M; Kudo H; Nakayama W; Inoue K; Nakashima T; Honda N; Fukushima S; Ihn H
Exp Dermatol; 2016 Feb; 25(2):131-6. PubMed ID: 26566700
[TBL] [Abstract][Full Text] [Related]
30. Long non-coding RNA HOTAIR drives EZH2-dependent myofibroblast activation in systemic sclerosis through miRNA 34a-dependent activation of NOTCH.
Wasson CW; Abignano G; Hermes H; Malaab M; Ross RL; Jimenez SA; Chang HY; Feghali-Bostwick CA; Del Galdo F
Ann Rheum Dis; 2020 Apr; 79(4):507-517. PubMed ID: 32041748
[TBL] [Abstract][Full Text] [Related]
31. Emerging role of lncRNAs in systemic lupus erythematosus.
Zhao CN; Mao YM; Liu LN; Li XM; Wang DG; Pan HF
Biomed Pharmacother; 2018 Oct; 106():584-592. PubMed ID: 29990846
[TBL] [Abstract][Full Text] [Related]
32. The Epigenetic Regulation of Scleroderma and Its Clinical Application.
Luo Y; Xiao R
Adv Exp Med Biol; 2020; 1253():375-403. PubMed ID: 32445102
[TBL] [Abstract][Full Text] [Related]
33. Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis.
Abraham D; Lescoat A; Stratton R
Mol Aspects Med; 2024 Apr; 96():101252. PubMed ID: 38325132
[TBL] [Abstract][Full Text] [Related]
34. Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy.
Henry TW; Mendoza FA; Jimenez SA
Autoimmun Rev; 2019 Nov; 18(11):102396. PubMed ID: 31520794
[TBL] [Abstract][Full Text] [Related]
35. New pathogenic and therapeutic concepts in systemic sclerosis.
Hügle T; Huigens CA; van Laar JM
Arzneimittelforschung; 2009; 59(12):615-24. PubMed ID: 20108646
[TBL] [Abstract][Full Text] [Related]
36. Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis.
Korman B
Transl Res; 2019 Jul; 209():77-89. PubMed ID: 30876809
[TBL] [Abstract][Full Text] [Related]
37. Perspective to precision medicine in scleroderma.
Komura K; Yanaba K; Bouaziz JD; Yoshizaki A; Hasegawa M; Varga J; Takehara K; Matsushita T
Front Immunol; 2023; 14():1298665. PubMed ID: 38304250
[TBL] [Abstract][Full Text] [Related]
38. Immunogenetics of systemic sclerosis: Defining heritability, functional variants and shared-autoimmunity pathways.
Bossini-Castillo L; López-Isac E; Martín J
J Autoimmun; 2015 Nov; 64():53-65. PubMed ID: 26212856
[TBL] [Abstract][Full Text] [Related]
39. Emerging roles of long non-coding RNAs in the pathogenesis of Alzheimer's disease.
Cortini F; Roma F; Villa C
Ageing Res Rev; 2019 Mar; 50():19-26. PubMed ID: 30610928
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma.
Zhu H; Luo H; Zuo X
Exp Mol Med; 2013 Sep; 45(9):e41. PubMed ID: 24052166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
